Does regular treatment with ketotifen inhibit bronchoconstriction induced by isocapnic hyperventilation?
Paul Rafferty, P.M. Tweeddale, RJ Ferguson, Beverley‐Ann Biggs, Ian W B Grant
Abstract
Open-access reader
Paul Rafferty, P.M. Tweeddale, RJ Ferguson, Beverley‐Ann Biggs, Ian W B Grant
Abstract
Open-access reader
Eight asthmatic patients completed a 12-week, double-blind, placebo controlled study to assess the efficacy of ketotifen, 1 mg twice daily, in the inhibition of bronchoconstriction induced by isocapnic hyperventilation (IH). There was no significant difference in the degree of bronchoconstriction produced by IH after treatment with ketotifen or placebo.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Eight asthmatic patients completed a 12-week, double-blind, placebo controlled study to assess the efficacy of ketotifen, 1 mg twice daily, in the inhibition of bronchoconstriction induced by isocapnic hyperventilation (IH). There was no significant difference in the degree of bronchoconstriction produced by IH after treatment with ketotifen or placebo.
Key concepts: Ketotifen, Bronchoconstriction, Hyperventilation, Placebo, Anesthesia, Medicine, Asthma, Internal medicine